Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients
A trial of lixisenatide to assess its effects in early Parkinson’s disease.
https://www.news-medical.net/n....ews/20240418/Phase-2
![image](https://altruu22oopsliteclo1vbudbacnso.s3.amazonaws.com/upload/photos/2024/04/EBwkSj5LULnBYD59XoB4_url_image.jpg)
Discover the world at Altruu, The Discovery Engine